Company / Shares Outstanding
TherapeuticsMD, Inc. Shares Outstanding History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
11.5M
FY2024
5-year range
8.6M / 299.8M
FY2020-FY2024
Trend
+21.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 8598000.00 to 11532000.00 over the past 2 years.
Based on SEC 10-K filings.
11532000.00 in FY2024 with a 5-year CAGR of -45.5%.
Increased from 8598000.00 to 11532000.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -66.2%
- 5-Year CAGR
- -45.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shares outstanding increased 21.4% year-over-year.
- Peak shares outstanding was recorded in FY2021.
- Lowest shares outstanding in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 11.5M | +21.4% |
| FY2023 | 9.5M | +10.5% |
| FY2022 | 8.6M | -97.1% |
| FY2021 | 299.8M | +10.5% |
| FY2020 | 271.2M | +12.8% |
| FY2019 | 240.5M | +11.1% |
| FY2018 | 216.4M | +10.0% |
| FY2017 | 196.7M | +10.5% |
| FY2016 | 177.9M | +22.7% |
| FY2015 | 145.0M | +0.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026